Dr Christopher Booth explores the concept of time toxicity which means understanding it from the patient’s perspective. Time toxicity includes how much time is spent by patients in time seeking cancer care.
He talks about why clinical trials need to incorporate time toxicity within their findings to improve the quality of care.
Dr Booth mentions gauging clinically meaningful benefits from trials.
One of the major problems within the field of cancer care is that increasingly many new medicines have very small benefits.
The side effects of these medicines could lead to impairments and reduced quality of life.